TCR2 Therapeutics (TCRR) PT Lowered to $23 at Piper Sandler
Tweet
Share
E-mailGet Alerts TCRR Hot Sheet
Price: $2.89 -0.34%
Rating Summary:
7 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Rating Summary:
7 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Join SI Premium – FREE
Piper Sandler analyst Do Kim lowered the price target on TCR2 Therapeutics (NASDAQ: TCRR) to $23.00 (from $26.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Perpetual Ltd (PPT:AU) (PRPLF) PT Lowered to AUD34 at Credit Suisse
- Credit Suisse Upgrades Platinum Asset Management Ltd. (PTM:AU) (PTMGF) to Neutral
- Pendal Group Ltd (PDL:AU) PT Lowered to AUD4 at Credit Suisse
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
